418 Results

People

  1. Saltz
    Saltz
  2. Lee
    Lee
  3. Kemeny
    Kemeny
  4. Ilson
    Ilson
  5. Lichtman
    Lichtman
  6. Lacouture
    Lacouture
  7. Fury
    Fury
  8. Pfister
    Pfister
  9. Riaz
    Riaz
  10. Sherman
    Sherman

Groups

  1. Department of Medicine (281)
  2. Solid Tumor Oncology Division (252)
  3. Gastrointestinal Oncology Service (131)
  4. Survivorship Research (72)
  5. Surgery (68)
  6. Center for Pancreatic Cancer Research (50)
  7. GSK Faculty (50)
  8. Radiation Oncology, Department of (44)
  9. Department of Pathology and Laboratory Medicine (38)
  10. Division of Subspecialty Medicine (38)
  1. "cetuximab"
Formats
  1. Journal Article (388)
  2. Review (20)
  3. Editorial (3)
  4. Correspondence (2)
  5. Guidelines (2)
  6. Book Section (1)
  7. Conference Paper (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (281)
  2. Solid Tumor Oncology Division (252)
  3. Gastrointestinal Oncology Service (131)
  4. Survivorship Research (72)
  5. Surgery (68)
  6. Center for Pancreatic Cancer Research (50)

More Groups

People
  1. Leonard Saltz (51)
  2. Nancy Lee (33)
  3. Nancy Kemeny (25)
  4. David Ilson (20)
  5. Eric Sherman (20)
  6. Mario Lacouture (20)

More People

Years
  1. 2025 (8)
  2. 2024 (22)
  3. 2023 (6)
  4. 2022 (9)
  5. 2021 (6)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Journal of the National Comprehensive Cancer Network (18)
  3. Oncology (Norwalk) (11)
  4. Cancer (10)
  5. Clinical Cancer Research (10)
  6. The Oncologist (10)

More Publications

Publishers
  1. Elsevier Inc. (78)
  2. Springer (35)
  3. American Society of Clinical Oncology (33)
  4. American Association for Cancer Research (22)
  5. Oxford University Press (22)
  6. Wiley Blackwell (19)

More Publishers

Results (418)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Irinotecan in metastatic colorectal cancer: Dose intensification and combination with new agents, including biological response modifiers
    Conference Paper

    Ducreux, M.; KoĢˆhne, C. H.; Schwartz, G. K.; Vanhoefer, U.
    Oxford University Press (2003)

    Fulltext@MSK | Save
  • Editorial: States and state transitions are all that really matter
    Journal Article

    Scher, H. I.; Kelly, W. K.
    Journal of Urology (2002)

    Fulltext@MSK | Save
  • Metastatic neoplasms to the lung: Introduction
    Journal Article

    Rusch, V. W.
    Seminars in Thoracic and Cardiovascular Surgery (2002)

    Fulltext@MSK | Save
  • New approaches in the treatment of non-small cell lung cancer: Taxanes in the treatment of NSCLC: Pathways to progress
    Journal Article

    Kris, M. G.; Tonato, M.
    Lung Cancer (2002)

    Fulltext@MSK | Save
  • Clinical issues in the administration of an anti-epidermal growth factor receptor monoclonal antibody, IMC-C225
    Journal Article

    Hollywood, E.
    Seminars in Oncology Nursing (2002)

    Fulltext@MSK | Save
  • Novel therapies for the treatment of prostate cancer: Current clinical trials and development strategies
    Journal Article

    Morris, M. J.; Scher, H. I.
    Surgical Oncology (2002)

    Fulltext@MSK | Save
  • Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225
    Journal Article

    Busam, K. J.; Capodieci, P.; Motzer, R.; Kiehn, T.; Phelan, D.; Halpern, A. C.
    British Journal of Dermatology (2001)

    Fulltext@MSK | Save
  • The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma
    Journal Article

    Prewett, M.; Rockwell, P.; Rockwell, R. F.; Giorgio, N. A.; Mendelsohn, J.; Scher, H. I.; Goldstein, N. I.
    Journal of Immunotherapy (1996)

    Fulltext@MSK | Save